http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021043276-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cd7b31284003c999afe5eab39372c34 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B30-10 |
| filingDate | 2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80f3818ca2e1d5fa36d47a2c8f4b5c6 |
| publicationDate | 2021-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021043276-A1 |
| titleOfInvention | Methods of identification condition-associated t cell receptor or b cell receptor |
| abstract | Ability to efficiently identify T cell receptor (TCR) or B cell receptor (BCR) sequence variants associated with particular disease conditions is a prerequisite for development of wide diagnostics based on immune receptor repertoires analysis. It would also contribute to precise TCR- or BCR-based immunotherapies of infections and cancer, as well as to the treatment of autoimmune diseases and allergies by targeted elimination of disease-associated T cell or B cell clones. Provided herein are methods for using the data on immune receptor repertoires to identify condition-associated TCR or BCR sequence variants or groups of homologous variants in cohorts of patients with particular disease conditions, or undergoing particular therapy or vaccination. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022192699-A1 |
| priorityDate | 2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.